GS1 Healthcare Conference · 10:15 am – 12:30 pm PLENARY SESSION (open to all) rdChat room (3 floor) 10:15 am – 10:30 am Welcome Shurou Karashima, Chairman, GS1 Japan Michel van

GS1 Healthcare Conference

28-30 October 2008 Happo-en, Tokyo, Japan

GS1 Healthcare – Improving patient safety worldwide

1

GS1 Healthcare Conference Tokyo, Japan, 28-30 October 2008

Table of Contents Acknowledgements ......................................................................................................... 1

Welcome ......................................................................................................................... 2

Conference Agenda ........................................................................................................ 3

Conference Venue .......................................................................................................... 6

Networking Dinner ........................................................................................................... 9

Post-Conference Hospital Tours .................................................................................... 10

Plenary Speakers .......................................................................................................... 11

GS1 Healthcare Work Teams ........................................................................................ 16

List of participants ......................................................................................................... 17

Acknowledgements

This conference is co-hosted with:

GS1 Healthcare and GS1 Japan would like to thank the following organisations for supporting this global conference:

− MHLW, Japan (Ministry of Health, Labor and Welfare)

− METI, Japan (Ministry of Economy, Trade and Industry)

− Japan Hospital Association

− JFMDA (the Japanese Federation of Medical Devices Associations)

− FPMAJ (the Federation of Pharmaceutical Manufacturers’ Associations of Japan)

− The Federation of Japanese Pharmaceutical Wholesalers Association

− The Medical Information System Development Center

− Japan Automatic Identification Systems Association In addition, we would like to thank:

- all speakers for sharing their insights in automatic identification, traceability of data management in the Healthcare supply chain

- the Kyoto Second Red Cross Hospital and the International Medical Center of Japan (Tokyo) for providing us with a peek behind the scenes of their hospitals and demonstrating their state-of-the-art data capturing systems

- Sakura Seiki Co. and Sakura Finetek Co. for offering a USB key for all participants, Asahi Printing Co. for offering memo pads and SATO Co. for offering sample patient wristbands.


2


Welcome

“Raising the bar on patient safety and efficiency” Dear Participant, Welcome to the global GS1 Healthcare Conference in Tokyo, the first one ever in Asia-Pacific. Three days of information exchange, collaboration, networking and sharing of ideas advancing GS1 Standards in the Healthcare supply chain. Security, traceability and efficiency in healthcare are currently at the forefront of government regulations and industry concerns around the world. As a result, numerous, and often irreconcilable solutions are being (or have already been) proposed to the national and international supply chain stakeholders. The cost of diverse government regulations, proprietary service offerings and incompatible solutions to all stakeholders has called for defining and adopting global and open standards. The Japanese Ministry of Health, Labour and Welfare, together with the JFMDA, has published earlier this year a revised bar code guideline for medical devices to bring it fully in line with GS1 Standards. This was another important milestone towards global harmonisation of Healthcare supply chain standards. We also see other promising developments in Asia-Pacific and the rest of the world. The US FDA is for example strongly advocating global standards through the Global Harmonisation Task Force. Opinion leaders and experts from the US FDA, several Japanese ministries and associations, the Chinese Ministry of Health, the Shanghai FDA, the Hong Kong Hospital Authorities, as well as other stakeholders will share their insights on standardisation and global harmonisation for automatic identification, traceability and data synchronisation in Healthcare. The work team sessions will allow you to contribute to the ongoing global standards development process. Special thanks to GS1 Japan for their support in organising this conference. Thank you for participating to the GS1 Healthcare Conference. We hope you will have an interesting, challenging and educational few days. Best regards,

Michel van der Heijden President Healthcare, GS1 Global Office


3


Conference Agenda

Tuesday, 28 October 2008

8:30 am Opening registration

9:00 am – 10:00 am PRIMER SESSION (open to all) Chat room (3rd floor)

9:00 am – 10:00 am Training Session: Introduction to GS1 Standards

10:00 am – 10:15 am Coffee break Lobby (3rd floor)

10:15 am – 12:30 pm PLENARY SESSION (open to all) Chat room (3rd floor)

10:15 am – 10:30 am Welcome Shurou Karashima, Chairman, GS1 Japan Michel van der Heijden, President Healthcare, GS1 Global Office

10:30 am – 10:45 am MHLW, Japanese Ministry of Health, Labour and Welfare Kenshi Kinoshita, Director, Economic Affairs Division

10:45 am – 11:00 am METI, Japanese Ministry of Economy, Trade and Industry Naoto Takahashi, Director, Distribution and Logistics Policy Division, Commerce and Distribution Policy Group

11:00am – 11:15 am JFMDA, Japanese Federation Medical Devices Association Takashi Wachi, Japanese Federation of Medical Devices Associations

11:15 am – 11:40 am Traceability for patient safety in Japan Takashi Taniguchi, Japanese Ministry of Health, Labour and Welfare

11:40 am – 12:05 pm Promoting patient safety: is technology the solution? UDI & the FDA perspective Jay Crowley, Senior Advisor, US FDA

12:05 pm – 12:30 pm Shanghai regulation on traceability of implants Liang Yan, Director of Legal & International Affairs, Shanghai FDA

12:30 pm – 2:00 pm Lunch Leaf/Sunlight room (2nd floor)

2:00 pm – 6:00 pm BREAKOUT SESSIONS

2:00 pm – 6:00 pm

Work Teams – parallel sessions (open to end-users) - AIDC Application Standards Chat room (3rd floor) - Global Data Synchronisation & Product Classification

Grace room (3rd floor)

6:00 pm – 7:00 pm Welcome Drink Lobby (3rd floor)


4


Wednesday, 29 October 2008

9:00 am – 12:50 pm PLENARY SESSION (open to all) Chat room (3rd floor)

9:00 am – 9:25 am Identification of medical devices – Manufacturer case study Naomi Sekino, Manager, System Research, Olympus Medical System

9:25 am – 9:50 am Supply chain integrity – Wholesaler case study Kentaro Iwasaki, Vice President, Alfresa Corporation

9:50 am – 10:15 am RFID Management System for surgical devices – Hospital case study Dr. Chikayuki Ochiai, Kanto Medical Center NTT EC

10:15 am – 10:40 am

Australia National Product Catalogue and NeHTA eProcurement Pilot Robyn Richmond, Manager Strategic Development, Western Australia Health

10:40 am – 11:10 am Coffee break Lobby (3rd floor)

11:10 am – 11:35 am Implementation of GS1 standards at a sterilisation department – Hospital case study Michael Tamegger, Vienna Orthopaedic Hospital Speising, Austria

11:35 am – 12:00 pm Traceability system for metal apparatus - Hospital case study Dr. Kazumi Taki, Nagoya National University Hospital

12:00 pm – 12:25 pm Novartis strategy on serialisation and track & trace – Manufacturer case study Scott Cameron, Novartis Pharma A.G.

12:25 pm – 12:50 pm RFID Pilot using SGTIN – Hospital case study Prof. Masanori Akiyama, Tokyo Medical University, Japan

12:50 pm – 2:00 pm Lunch Jasmine/Cider room (5th floor)

2:00 pm – 6:00 pm BREAKOUT SESSIONS

2:00 pm – 6:00 pm

Work Teams – parallel sessions (open to end-users) - Global Data Synchronisation & Product Classification

Grace room (3rd floor) - Traceability in Healthcare Chat room (3rd floor)

Solution Provider Track (open to all) Linden room (5th floor)

6:30 pm – 8:30 pm Networking Dinner Hakuko kan


5


Thursday, 30 October 2008

9:00 am – 1:00 pm BREAKOUT SESSIONS

9:00 am – 1:00 pm Work Teams – parallel sessions (open to end-users)

- AIDC Application Standards Chat room (3rd floor) - Traceability in Healthcare Linden room (5th floor)

1:00 pm – 2:00 pm Lunch Leaf/Sunlight room (2nd floor)

2:00 pm – 5:30 pm PLENARY SESSION (open to all) Chat room (3rd floor)

2:00 pm – 2:25 pm National Pharmaceuticals & Medical Devices database in Japan Ryoji Takekuma, Manager, Standardization Promotion Department MEDIS-DC

2:25 pm – 2:50 pm Hong Kong Hospital Authorities Raymond Wong, Chief Manager (Business Support Services), HKHA

2:50 pm – 3:15 pm Chinese Ministry of Health Prof. Yanjie Gao, Director of Department of Information Technology for Healthcare, Ministry of Health China

3:15 pm – 3:40 pm Medical devices and patient safety in Japan Yuko Kitayama, Professional Officer, Medical Device Safety Division,Pharmaceuticals & Medical Devices Agency

3:40 pm – 4:10 pm Coffee break Lobby (3rd floor)

4:10 pm – 4:50 pm Worldwide progress in harmonisation of regulations, collaboration, adoption and implementation support GS1 Member Organisations

4:50 pm – 5:20 pm Conclusions work team sessions Co-chairs of the work teams

5:20 pm - 5:30 pm Closing remarks Mark Hoyle (Covidien) and Tim Marsh (Pfizer), Co-Chairs GS1 Healthcare

5:30 pm Closure of Conference


6


Conference Venue Happo-en 1-1-1 Shirokanedai, Minato-ku Tokyo , Japan

Happo-en 2nd floor

☆サ

ンラ

イト

& リ

ーフ☆

10月

28、

30日

昼食

Su

nlig

ht &

Le

af R

oo

m2

8 +

30

Oct.

Lu

nch


7


Happo-en 3rd floor 3階階階階 (Lobby)

10月

28日

トレー

ニング

& プ

レナリー

(AM

), A

IDC

(P

M)

10月

29日

プレナ

リー

(AM

), ト

レー

サビ

リティ

(PM

)10月

30日

AID

C(A

M),

プレ

ナリ

ー(P

M)

Gra

ce

Roo

m

28

+ 2

9 O

ct.

GD

SN

(P

M)

Ch

at R

oo

m

28 O

ct.

Pri

me

r &

Ple

na

ry (

AM

), A

IDC

(P

M)

29

Oct.

Ple

na

ry (

AM

), T

race

ab

ility

(P

M)

30

Oct.

AID

C (

AM

), P

len

ary

(P

M)

En

tra

nc

e

☆グレ

ース☆

10月2

8、2

9日

GD

SN

(P

M）

☆チャ

ット

☆

Lo

bb

y

28

Oct.

We

lco

me C

ockta

il

☆ロビ

ー☆1

0月2

8日

ウエルカ

ム・ドリ

ンク


8


Happo-en 5th floor 5階階階階

Jasm

ine &

Ced

ar

Roo

m29

O

ct. L

unch

Lin

den

Ro

om

29

Oct.

So

lutio

n P

rovid

er

Se

ssio

n (

PM

)

30 O

ct.

Tra

ce

abili

ty (

AM

)

☆リンデン☆

10月

29日ソリューションプロバイダ向け研修会

(PM

) 1

0月

30日トレーサビリティ

(AM

)

☆ジャスミン

& シダー☆

10月

29日昼食


9


Networking Dinner Wednesday 29 October 6:30 pm - 8:30 pm Hakuho-kan, Happo-en Dress Code: Business Casual

10月29日（水）

18時30分～20時30分

白鳳館, 八芳園

ドレスコード：ビジネスカジュアル

Ne

two

rkin

g

Din

ne

r V

en

ue

夕食懇親

会場

Hakuho-k

an 白鳳館

Ma

in B

uild

ing

本館

Po

nd

Bo

nsa

i

Ga

te

Sh

era

ton

Miy

ako

To

kyo

Ho

tel

シェラト

ン都

ホテル

東京

Sh

iro

ga

ne

da

iSta

tio

n 白

金台駅


10


Post-Conference Hospital Tours

Kyoto Second Red Cross Hospital tour & sightseeing in Kyoto – 31 October

Thursday, 30 October – Leaving for Kyoto

− Assembly for transfer to station: 6:45 pm - Lobby Sheraton Miyako Hotel Tokyo

− Shinkansen NOZOMI # 87 (JR Shinagawa St) 7:37 pm – 9:50 pm

− Expected arrival at Hotel Monterey (Kyoto): 10:15 pm Friday, 31 October

− Assembly: 9:15 am – Lobby Hotel Monterey Kyoto

− Kyoto Second Red Cross Hospital visit: 9:45 am – 12:15 pm

− Accompanying people: pick-up at 11:50 am Hotel Monterey Kyoto

− Lunch at local restaurant

− Visit to Golden Pavilion - Kiyomizu Temple - JR Kyoto St: 2:00 pm – 5:30 pm Including: transfers (bus & train), accommodation, meals, admission fees and guide

京都第二赤十字病院訪問京都第二赤十字病院訪問京都第二赤十字病院訪問京都第二赤十字病院訪問 + + + + 市内観光市内観光市内観光市内観光

10/30 （木）（木）（木）（木）

− シェラトン都ホテル東京ロビー 6:45 pm集合

− 新幹線のぞみ87(普通車指定席・お弁当) JR 品川駅 7:37 pm 品川発-9:50 pm 京都着

− ホテルモントレ京都 10:15 pm着

10/31 （金）（金）（金）（金）

− ホテルモントレ京都ロビー 9:15 am集合

− 京都第二赤十字病院見学 9:45 am - 12:15 pm

− 同伴者希望者のみホテル 11:50 am 発

− 昼食(レストラン）

− 金閣寺 - 清水寺 - JR 京都駅（解散） 2:00 pm – 5:30 pm 旅行代金には行程上の交通、宿泊、食事、入場券、ガイダンスが含まれます。

International Medical Center of Japan (Tokyo) tour

Friday, 31 October

− Assembly for transfer to hospital: 8:45 am - Lobby at Sheraton Miyako Hotel Tokyo

− 10:00 am – 1:00 pm: presentation by Hospital Director + visit to the hospital

− 1:00 pm transfer to Sheraton Miyako Hotel Including: transfer (bus), lunch, and English speaking assistant & interpreter

国立国際医療センター訪問国立国際医療センター訪問国立国際医療センター訪問国立国際医療センター訪問

10/31 (金）金）金）金）

− シェラトン都ホテル東京ロビー 8:45 am集合

− 10:00am -1:00 pm: 概要説明 ‐ 2班に分かれて見学 ‐ 昼食及び質疑応答

− 1:00 pm シェラトン都ホテル東京ホテルへ旅行代金には行程上の交通、食事が含まれます。


11


Plenary Speakers

Prof. Masanori AKIYAMA is visiting professor at the Massachusetts Institute of Technology Sloan School of Management and the Tokyo Medical University as well as assistant professor at Keio University School of Medicine and the Hamamatsu University School of Medicine. After his M.D. degree at the university of Tokushima he was working in the fields of urology and pathology before concentrating more on the field of Medical Informatics. From 1999 to 2002 he held a position in the Ministry of Health and Welfare in the Department of National Hospitals policy medical treatment section. Afterwards he joined the National Institute of Public Health as associated professor. Prof. Masanori Akiyama is the director of the Japan association for medical informatics.

Scott CAMERON is Head of the Global Application Solution Center for Sales & Distribution and Supply Chain Management at Novartis Pharmaceuticals AG in Basel Switzerland. Scott has the current responsibility to provide and support the solutions for AutoID and Serialisation. Prior to this position he was the Head of IT for the Pharma Global Supply Chain, and in this role was deeply involved from the beginning with the Novartis Pharma Product Security initiative. With more than 25 years experience in supply chain business processes and IT, Scott sees the benefits of actively driving standardization in the area of AutoID and patient safety. His current role in GS1 Healthcare is a member of the Leadership Team and Co-Chain of the Regulatory Work Group.

Jay CROWLEY is Senior Advisor for Patient Safety in FDA's Center for Devices and Radiological Health. Jay is interested in developing new methods and techniques to identify, analyze, and understand problems occurring from medical device use within the healthcare environment. He has been working at FDA for nearly 20 years in a variety of positions. Jay holds degrees in Risk Analysis and Engineering.

Prof. Yanjie GAO is Deputy Director of Department of Information Technology for Healthcare, Ministry of Health China. Prof. Gao is chairman of the hospital statistics information professional committee of the Chinese hospital association and Vice-President of the Chinese medicine information society. She has been engaged in promoting the work of the National Health Information Management for more than 20 years. She has presided and framed the envelopment planning of Chinese health information system and was responsible health management information systems and card technology. She had been responsible for many national scientific and technological projects and major projects. Prof. Gao was selected Top 10 Excellent Woman in IT application of China and received the John Nuveen Center scholar award, University of Illinois, U.S.A.


12


Kentaro IWASAKI is Director Deputy President and Executive Officer of Alfresa Corporation. Iwasaki’s career with Alfresa began when he joined Taishodo Co. in 1977. Iwasaki was appointed Director of 1980 and ultimately Chairman in 2005. In 2005, Taishodo Co., Fukujin Co., and AZWELL Inc. merged and formed Alfresa Corporation at which time he was appointed to his current position. In addition to his current position, Mr. Iwasaki is involved with the Federation of Japan Pharmaceutical Wholesalers Association as Executive Director, with Pro-Net, VAN Industry as Chairman and Medicode as Board Member. Kentaro Iwasaki received his bachelor’s degree of Pharmaceutical Science from Tokyo University of Pharmacy Life Science in 1972. He also received his pharmacist license in 1972. In 1974 Iwasaki received his bachelor’s degree of Economic Administration from Aoyama Gakuin University.

Shuro KARASHIMA was appointed as the new President of GS1 Japan as of 6th June 2008. Mr. Karashima served as Vice Chairman and CEO of Japan Automobile Dealers Association for 6 years before joining GS1 Japan. He had worked at MITI (Ministry of International Trade and Industries) for 27years in various bureaus including Natural Resources & Energy Agency and Patent Office after he graduated the University of Tokyo (Faculty of Law) in 1964.

Kenshi KINOSHITA is Director, Economic Affairs Division, Health Policy Bureau, Ministry of Health, Labour and Welfare. He has been working for MHLW for 25 years in various fields such as national health insurance, public pension system, social welfare, etc., since he graduated the faculty of Economics of Hitotsubashi University in 1983.

Yuko KITAYAMA belongs to the Medical Device Safety Division and Medical Safety Information Group in PMDA (Pharmaceuticals and Medical Devices Agency), Japan. Since April 2006, she has specialised in post marketing regulation for medical devices and proper use of pharmaceutical products (in particular, similarity assessment of drug naming and proper indication of drug packaging), working as a Professional Officer in the agency. She has also worked as a hospital pharmacist in the International Medical Center of Japan and other hospitals for ten years. She received a BS degree in Pharmacy from Hoshi University, Tokyo, Japan


13


Dr. Chikayuki OCHIAI is the Chief Executive of Kanto Medical Center NTT EC in which an electronic medical record (EMR) was introduced in 2000. After graduating from the University of Tokyo, Faculty of Medicine in 1971 he majored in neurosurgery. Before being promoted to his current position in 2002, he held various posts including an instructor of neurosurgery in the University of Tokyo Hospital, an assistant professor of neurosurgery in Dokkyo University School of Medicine, a head of neurosurgery in JR Tokyo General Hospital, and a head of Neurosurgery in Kanto Teishin Hospital (present Kanto Medical Center NTT EC). He experienced more than two thousands surgical cases in his career as a neurological surgeon.

Robyn RICHMOND is Manager of the Strategic Development Branch, Health Corporate Network for the Western Australian Department of Health (WA Health). The Strategic Development Branch has responsibility for procurement reform including system and business process efficiency, procurement information management and contract performance management for the WA Health supply chain. Robyn has worked for WA Health for 20 years including 13 years experience in supply chain management. For the past 3 years Robyn has represented WA Health on the National E-Health Transition Authority (NeHTA) Supply Chain Project Control Group responsible for the Australia National Product Catalogue and developing standards for E-procurement.

Naomi SEKINO is R&D Manager of the System Integration Department at Olympus Medical Systems Corporation, which is a leading manufacturing company of endoscope systems. He has developed many laproscopic instruments and therapautic devices acting as chief product engineer for many years. He is now responsible for the identification pilot of a surgical endoscopic system using 2D bar code and RFID in conjunction with Osaka University Hospital. He has also participated in GS1 Healthcare Conferences and international discussions regarding autoID methods for medical devices with the Work Team of “Instrument and Implant marking” and also with “AIDC” since 2006.

Naoto TAKAHASHI is Director, Distribution and Logistics Policy Division, commerce and Distribution Policy Group, Ministry of Economy, Trade and Industry (METI). He joined METI after graduating the Faculty of Law of Tokyo University in 1988, and has been engaged on policy making tasks in a wide variety of fields including national energy strategy and consumer electronics recycling system. He had served as a Consulate at Consulates General in San Francisco from 2001 through 2004.


14


Ryoji TAKEKUMA is Manager for Standardisation Promotion Department in Medical Information System Development Center (MEDIS-DC). MEDIS-DC was established as a legally incorporated foundation recognised by the Ministry of Health, Labour and Welfare (MHLW) and by the Ministry of Economy, Trade and Industry (MITI). He is interested in standardisation of terminology and code in Medical Information. For example, he is doing the maintenance of Database of Prescription drugs, Medical devices, Disease, Surgery & treatment and Clinical Laboratory. Mr. Takekuma holds a degree in pharmacy. He has worke at MHLW for 20 years in a variety of position.

Dr. Kazumi TAKI is former associate professor of Operation Theater, Nagoya University Hospital. Dr. Taki has worked in ER, ICU and OT of the Red Cross Hospital and the Citizen Hospital as a clinical anesthetist. Appointed as an associate professor of the OT of Nagoya University Hospital in 1990, he began his career in developing medical devices and hospital facilities. Later he was in charge of design, building and operation of the new OT and the central supply center of the hospital which were completed in December, 2006. Dr. Taki is managing an institution for elderly people’s health since March 2007.

Michael TAMEGGER works as a project manager at the Orthopaedic hospital Speising in Vienna. This hospital is one of seven hospitals of the Vinzenz Group Austria. His responsibilities include all the projects to identify and trace of persons and things in the hospital. Mr. Tamegger completed his degree as an Engineer and started to work at the hospital as a biomedical technician, where he learned a lot about hospital processes. He has also completed a hospital management degree and a Master of Business Administration for Healthcare Management at the Economic University of Vienna. He is currently working on projects for serialisation and traceability of sterilisation trays and containers, patient identification by using RFID technology and optimising the administration of patients by using the GS1 System.

Dr. Takashi TANIGUCHI joined the Ministry of Health, Labor and Welfare in 1984 after graduating at the medical department of Okayama University in 1979. Before being appointed as Assistant Minister for Technical Affairs of Minister’s Secretariat in 2008, he has worked in various positions at the MHLW, including Director of Maternal and Child Health Division, Guidance of Medical Service Division. He has also served in the International Medical Center of Japan as Director General from 2006 through 2007, as well as in the Ministry of Agriculture, Forestry and Fisheries as Deputy Director-General of Minister’s Secretariat from 2007 through 2008.


15


Michel VAN DER HEIJDEN is President Healthcare at GS1. His other responsibilities include Finance and Administration, Strategic Alliances and New Sectors. Michel brings with him a wealth of global management experience in international business activities, particular in the Healthcare Industry. His professional career spans work and knowledge in international finance, information systems, human resources and turn-around management. Michel spent 20 years with Johnson & Johnson, heading local and regional CFO functions in the companies Pharmaceutical, Consumer Goods and Medical Device units. He also spent 3 years with Novartis (Pharma) in Switzerland as the global CFO for Primary Care and has lived and worked in 6 countries, namely Belgium, the Netherlands, Mexico, US, Greece and Switzerland.

Takashi WACHI is Chairman of Japan Federation of Medical Devices Associations. He joined Terumo Corporation in 1989 after he had worked for Fuji Bank for almost 30 years since his graduation from Yokohama National University. He has been the chairman of the Board of Directors, Terumo Corp. since June 2006. He is also Executive Member of the Board of Directors, Japan Business Federation and Chairman of Japan Medical Devices Manufacturers Association.

Raymond WONG is Head of the Business Support Services at the Hong Kong Hospital Authority Head Office. He is the Senior Executive in charge of procurement, support services and biomedical engineering services and a facility planner in the Hospital Authority. He is presently steering the development and implementation of corporate improvements in procurement and supplies logistics support, together with ERP technology and system applications in supply chain operations. Mr Wong was the General Manager of Queen Mary Hospital between 1991 and 2001. Mr. Wong is also the Chairman of the Society for Promotion of Hospice Care, Member of Board of Governors of the Institute for Health Policy and Systems Research and a volunteer of the Phoenix Clubhouse for psychiatric patients in Hong Kong. He received his M.Sc. degree in Public Sector Management with PSM Prise Award from Aston Business School.

Liang YAN was the Director of International and Legal Affairs of the Shanghai Municipal Food and Drug Administration (SH-FDA). He retired last month and is now a senior consultant of the SH-FDA. He has designed the UDI system in recent years for tracking implantable device in Shanghai. In 1989, he chaired a group for drafting China's first medical devices regulations. Afterwards, he continued to contribute in the China’s regulation project on Medical Device Registration, Classification Rules, and Medical Devices Recall. He was the medical device registration chief in SH-FDA more than 10 years, and he was also chief project organiser for China’s first whole body CT and ultrasound diagnostic set in the 80's.


16


GS1 Healthcare Work Teams

AIDC Application Standards Work Team The objective of this work team is to develop global standards for the automatic identification and data capture for Healthcare products at all packaging levels. The work team has already developed GTIN Allocation Rules for Healthcare, defined data requirements (including Serialization) and carrier requirements for Automatic Identification. The work team is currently finalising the draft AIDC Application Standards for a majority of product types and packaging levels, which will be further discussed during this conference. This work team is co-chaired by Mark Hoyle, Covidien and Grant Hodgkins, Alcon Laboratories. For more information or to join, contact Tom Heist at [email protected].

Traceability in Healthcare Work Team The objective of this work team is to define the global solution for traceability in Healthcare to ensure that the business needs of the industry are fulfilled, including ensuring global traceability in an efficient, secure and reliable way, addressing restrictive legal requirements, addressing authentication from manufacturer to patient, and achieving cross-industry interoperability. The work team has recently submitted the draft Global Traceability Standard for Healthcare into the GS1 Global Standards Management Process (GSMP). Implementation guidelines, case studies, and best practices are currently being drafted. The Traceability in Healthcare Work Team is co-chaired by Tim Marsh, Pfizer and Frédérique Fremont, Robert Ballanger Hospital. For more information or to join, contact Janice Kite at [email protected].

Data Synchronisation & Product Classification Work Team The objective of this work team is to develop a data synchronisation standard, including a classification solution, which will allow the Healthcare industry to use the GS1 GDSN (Global Data Synchronisation Network). The GDSN gap analysis showed that 228 data requirements are supported by the current GDSN standard and 27 new requirements need to be defined and added to the GDSN standard. The classification systems in use across the world have been inventorised: approximately 35 different classification and nomenclature systems are in use in various parts of the world. A global GDSN Pilot was successfully completed earlier this year. The GDSN Extension for Healthcare is planned to be created by Q2 2009. A long term recommendation for product classification is also being developed. The Data Synchronisation Work Team is co-chaired by Joe Pleasant, Premier and Tom Werthwine, Johnson & Johnson. The Product Classification Work Team is co-chaired by Leighton Hansel, Abbott Laboratories and David Turner, Novation. For more information or to join, contact Peter Alvarez at [email protected].


17


List of participants

First name Last name Company / Organisation

Zemirli Abderrahmane Redouane GS1 Algeria

Masanori Akiyama MIT Sloan school of management

Yuji Akiyama Ministry of Health, Labour, Welfare

Peter Alvarez GS1 GDSN, Inc.

Kazuki Arai Medtronic

Koji Asano GS1 Japan

Ryuichiro Azuma Sakura Seiki Co., Ltd.

Masatoshi Baba Asahi Kasei Kuraray Medical Co.,Ltd.

Scott Barger Sentient Health Japan, KK

Bettina Bartz GS1 Germany GmbH

Chuck Biss GS1 Global Office

Scott Cameron Novartis Pharma AG

Tai Wai, David Chan Hospital Authority, Hong Kong SAR

Lifang Chen Johnson & Johnson Medical China

Andy Chung Hospital Authority Head Office

Jay Crowley US Food and Drug Administration

Ogbuagu Daniel Lagos University Teaching Hospital

Isaac Danso-Boafo Richbone Initiative Foundation

Jan Denecker GS1 Global Office

Mangkorn Dhanasarnsilp GS1 Thailand

Ljiljana Djukic Medicines and Medical Devices Agency of Serbia

Satoshi Dokai Asahi Printing Co.

Barbara Dorner GS1 Austria

Alicia Duval GS1 Canada

Mime Egami Tokyo Women’s Medical University

Jackie Elkin Medtronic, Inc.

Vicente Escribano GS1 Global Office

Nakamori Etsuhiko Alfresa Corporation

Nicolas Florin GS1 Switzerland

May Fok Hong Kong Hospital Authority

Dawn Fowler Edwards Lifesciences

Frédérique Fremont Hospital of Aulnay

Kotaro Fukuda Fukuda Denshi Co.,Ltd.

Yanjie Gao China Ministry of Health

Wolfgang Gerold Vienna Hospital Association

Masakazu Gotanda Olympus Medical Systems

Scott Gray GS1 Global Office


18



Michio Hamano GS1 Japan

Deming Hao Shanghai Red Cross Information and Technology Co.

Dennis Harrison GS1 US

Fujiko Hasegawa International University of Health and Welfare

Shiro Hatsugano Smiths Medical Japan Ltd.

Christian Hay GS1 Switzerland

Masaaki Hayashi Daiichi Medical co.,ltd.

Tom Heist GS1 Global Office

Tracey Herres GlaxoSmithKline

Ohmichi Hisashi Nihon University School of Medicine

Tosiho Horiuchi Eisai Distribution Co.

Mark Hoyle Covidien

Wai Kuen Barbara Hsui Hong Kong Hospital Authority

Hideki Ichihara GS1 Japan

Itsusei Ichiyama Federation of Japanese Pharmaceutical Wholesaler Association

Hiroshi Igarashi Japan Ministry of Health, Labour and Welfare

Yuichi Inoue Alphatec Pasific K.K.

Hiroshi Iseki Tokyo Women's Medical University

Junko Ito Hitachi,Ltd.

Kentaro Iwasaki Alfresa Corporation

Kiyotaka Iwasaki Waseda University

Chihiro Jonen GS1 Japan

Shigekoto Kaihara International University of Health and Welfare

Ji Seon Kang Health Insurance Review & Assessment Service

Masahiro Kanno Federation of Japanese Pharmaceutical Wholesalers Association

Noriko Kanzaki St. Jude Medical Japan Co., Ltd.

Shuro Karashima GS1 Japan

Yosuke Kasahara Medi-Care Information Laboratory Inc.

Ikuo Kato Chugai Pharmaceutical Co.

Hiroyuki Kawaguchi Sakura Seiki Co.

Momoyo Kawai Japan Council for Quality Health Care

Minoru Kawakami MediTrack Corporation

Yoichiro Kawanami Astellas Pharma Inc.

Shahid Hameed Khan National Youth Organization of Pakistan

Ho Won Kim GS1 Korea

Yoshihiro Kimura Terumo Corporation

Toyohiko Kimura Tokyo Medical industry Association

Kenshi Kinoshita Japanese Ministry of Health, Labour and Welfare


19



Yuko Kitayama Pharmaceuticals and Medical Devices Agency

Janice Kite GS1 Global Office

Tatsuya Kondo Pharmaceuticals and Medical Devices Agency

Katsuyuki Kondoh Akita University Hospital

Atsushi Koshio Massachusetts Institute of Technology

Ulrike Kreysa GS1 Global Office

Yasuo Kurosawa GS1 Japan

Roger Lamb GS1 UK

Chun Loy LAU Hong Kong Hospital Authority

Rita Laur GS1 Canada

Conser Lee GS1 Hong Kong

Wai Mei Liew GS1 Malaysia

Anna Lin GS1 Hong Kong

Miguel Lopera GS1 Global Office

Qiuke Luo GS1 China

Giuseppe Luscia GS1 Italy

Valérie Marchand GS1 France

Akira Masunaga Medical and Assistive Device Industries Office, Ministry of Economy, Trade and Industry

Tamio Matsumoto The Japan Federation of Medical Devices Associations

Kenichi Matsumoto Sakura Seiki Co.

Chikashi Mikami Tyco Healthcare Japan (Covidien Japan)

Branislava Mitic GS1 Serbia

Yamato Miyahara GS1 Japan

Naoko Mori GS1 Japan

Reiko Moritani GS1 Japan

Hideki Morohira Japan Association of Health Industry Distributors

Nadège Mullier GS1 Global Office

Satoko Munemura Fukuda Denshi

Hiroyuki Murai Eisai Distribution Co. .

Akio Murata Muranaka Medical Instruments Co.

Masayuki Nagahori Japan Association of Medical Equipment Industries

Yasushi Nagasawa Kogakuin University

sumako nakamura University of Tokyo

Seizoh Nakata Itami City Hospital

Kazuo Naoi Tyco Healthcare Japan Inc.

Raymond Ng GS1 Hong Kong

Yoshikazu Niiyama Eisai Distribution Co.

Ruzica Nikolic Ministry of Health, Republic of Serbia

Yoshitaka Nomoto Edwards Lifesciences Limited


20



Chikayuki Ochiai Kanto Medical Center NTT EC

Kimio Ogose Cook Japan

Yukiko Ohara Tokyo Medical university

Yoshio Ohta Okayama University Hospital

Miwa Okubo Japan Council for Quality Health Care

Hiroshi Okuno IMI Co.Ltd

Temitope Oluyemi NAFDAC

Akio Ooki Medicon, Inc.

Masao Osaki Osaki Medical Co.,Ltd.

Sakiko Ota Tokyo medical and Dental University

Zdenek Pav University hospital PLZEN

Manfred Piller GS1 Austria

Cyndi Poetker Abbott

Omar Rbeida Libyan FDA

Halim Recham GS1 Algeria

Mahmod Rhima Libyan FDA

Robyn Richmond Western Australia Department of Health

Shotaro Saito Pastoral Computer System,Inc.

Hiroshi Sakai The commodity Futures Association of Japan

Jun Sakurai Ministry of Health, Labour and Welfare

Masami Sasabe Toray-Medical Co.,Ltd.

Masanao Sasaki Sakura Finetek Japan Co., Ltd.

Koichi Sato Hakujuji Co,.Ltd

Mariko Sato Japan Council for Quality Health Care

Hitomi Sekikawa GS1 Japan

Naomi Sekino Olympus Medical Systems

Eun Ha Seo Ministry for Health, Welfare and Family Affairs

Ayako Shimazaki GS1 Japan

Norio Shimizu Masimo Japan Corporation

Yuko Shimizu GS1 Japan

Hisao Shimizu Japan Medical Devices Manufactures Association

In Sook Shin Health Insurance Riview & Assessment Service

Hiroo Shiraishi Medical AIDC committee, Japan Automatic Identification Systems Association

Akihito Shito Century Medical,Inc.

Harayama Shuichi Japan Medical Dynamic Marketing INC.

Rico Shum Hong Kong Hospital Authority

Josef Simacek Pharmdata

George Simeon GS1 Global Office

Hiromu Sugimoto Hakujuji


21



Yuriko Sugimura Japan Council for Quality Health Care

Kenji Sumiya Japan Association of Medical Equipment Industries

Ryuta Suzuki The Federation of Japanese Pharmaceutical Wholesalers Association

Yukie Tachi GS1 Japan

Koichiro Takada Association of Medical Devices Information Network

Naoto Takahashi Japan Ministry of Economy, Trade and Industry

Minoru Takahashi Japan Association Of Medical Equipment Industries

Miyuki Takahashi Japan Council for Quality Health Care

Hiromitsu Takai Denso Wave Automatic Data Capture Division

orii Takao Kanto Medical Center NTT

Masaki Takashina Osaka University Hospital

Ryoji Takekuma The Medical Information System Development center

Masakatsu Takenaka Mediceo Paltac Holdings Co., Ltd.

Noriyuki Takeuchi Association of Medical Devices Information Network

Kazumi Taki Nagoya university hospital

Michael Tamegger Orthopädisches Spital Speising GmbH

Makoto Tamura American Chamber of Commerce in Japan

Shingo Tamura Cisco Systems

Yuichiro Tamura Association of Medical Devices Information Network

Makoto Tanaka Novartis Pharma K.K.

Shuji Tanida The Japan Federation of Medical Devices Associations

Takashi Taniguchi Ministry of Health, Labour and Welfare

Tomiko Tawaragi Ministry of Health, Labour and Welfare

Yuko Toriumi Smiths Medical Japan

Naokazu Tsuchiya Mitsubishi Tanabe Pharma Corporation

Shuji Tsuihiji Medtronic

Nobutaka Turushima Sakura Seiki Co.

Hiromu Ueno GS1 Japan

Pitchya Vajarodaya GS1 Thailand

Michel van der Heijden GS1 Global Office

Takashi Wachi Terumo Corp.

Mike Wallace Abbott Laboratories

Claes Wallér Cook Group Europe

JunYi Wang RedCross Information and Technology Co.,Ltd

Yuichi Watanabe Banyu (Merck)

Markus Weinert Aesculap AG

Jim Willmott Smiths Medical

Raymond Wong Hong Kong Hospital Authority

MJ Wylie GHX


22



Katsuya Yahata University of Occupational and Environmental Health, Japan

Haruna Yakubu George Adofo Enterprise

Kazuhisa Yamamoto Sanofi-Aventis K.K.

Mikio Yamanaka Banyu Pharmaceutical Co., Ltd.

Liang Yan Shanghai Municipal Food & Drug Administration(SH-FDA). Chian

Liu Ying Chang Cheng Loong Corp.

Kenichi Yasuhara The Federation of Japanese Pharmaceutical Wholesalers Association

Catherine Yip Hong Kong Hospital Authority

Syouichi Yokozawa Mediceo Paltac Holdings Co.

Daniel Yuen Novartis Pharma AG

Volker Zeinar B. Braun Group

Jing Zhang Regulatory Affairs and compliance

Documents

GS1 Healthcare Conference · 10:15 am – 12:30 pm PLENARY SESSION (open to all) rdChat room (3 floor) 10:15 am – 10:30 am Welcome Shurou Karashima, Chairman, GS1 Japan Michel van